Pilot-scale production of (S)-styrene oxide from styrene by recombinant Escherichia coli synthesizing styrene monooxygenase

Biotechnology and Bioengineering

Volumn 80, Issue 1, 2002, Pages 33-41

  Panke, Sven ^a   Held, Martin ^a   Wubbolts, Marcel G ^a,b   Witholt, Bernard ^a   Schmid, Andreas ^a  

^a ETH ZURICH   (Switzerland)

^b DSM Fine Chemicals Austria Nfg GmbH & Co KG   (Netherlands)

Author keywords

Biocatalysis; Escherichia coli; In situ product recovery; Integrated process; Pilot plant; S styrene oxide; Stereoselective epoxidation; Styrene monooxygenase

Indexed keywords

BIOCATALYSTS; CATALYSIS; ESCHERICHIA COLI; STYRENE; VOLUMETRIC ANALYSIS;

BIOTRANSFORMATION;

BIOTECHNOLOGY;

RECOMBINANT ENZYME; STYRENE OXIDE; STYRENE OXYGENASE; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE;

ARTICLE; BACTERIAL CELL; BACTERIAL METABOLISM; BACTERIAL STRAIN; BIOCATALYST; BIOTRANSFORMATION; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; EPOXIDATION; ESCHERICHIA COLI; FED BATCH REACTOR; GENETIC RECOMBINATION; LIQUID; NONHUMAN; OXIDATION; PILOT STUDY; PROTEIN METABOLISM; PSEUDOMONAS; PURIFICATION; STEREOCHEMISTRY; VOLUMETRY;

CELL LINE; EPOXY COMPOUNDS; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; OXYGENASES; PILOT PROJECTS; PSEUDOMONAS; RECOMBINATION, GENETIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STEREOISOMERISM; STYRENE;

ESCHERICHIA COLI; PSEUDOMONAS; PSEUDOMONAS SP.;

EID: 0037026952     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/bit.10346     Document Type: Article

References (80)

1. Bar R. 1987. Phase toxicity in a water-solvent two-liquid phase microbial system. In Laane C, Tramper J, and Lilly MD, editors. Biocatalysis in organic media. Amsterdam: Elsevier. p 147-153.
2. Bernasconi S, Orsini F, Sello G, Colmegna A, Galli E, Bestetti G. 2000. Bioconversion of substituted styrenes to the corresponding enantiomerically pure epoxides by a recombinant Escherichia coli strain. Tetrahed Lett 41:9157-9161.
3. Besse P, Veschambre H. 1994. Chemical and biological synthesis of chiral epoxides. Tetrahedron 50:8885-8927.
4. Bialy H. 1997. Biotechnology, bioremediation, and blue genes. Nat Biotechnol 15:110.
5. Blake JAR, Pritchard M, Ding S, Smith GCM, Burchell B, Wolf CR, Friedberg T. 1996. Coexpression of a human P450 (CYP3A4) and P450 reductase generates a highly functional monooxygenase system in Escherichia coli. FEBS Lett 397:210-214.
6. Bornscheuer UT, Altenbuchner J, Meyer HH. 1998. Directed evolution of an esterase for the stereoselective resolution of a key intermediate in the synthesis of epothilones. Biotechnol Bioeng 58:554-559.
7. Brand JM, Cruden DL, Zylstra GJ, Gibson DT. 1992. Stereospecific hydroxylation of indan by Escherichia coli containing the cloned toluene dioxygenase genes from Pseudomonas putida F1. Appl Environ Microbiol 58:3407-3409.
8. Brink LES, Tramper J. 1986. Modeling the effects of mass transfer on kinetics of propene epoxidation of immobilized Mycobacterium cells: 1. Pseudo-one-substrate conditions and negligible product inhibition. Enz Microb Technol 8:281-288.
9. Brühlmann F, Chen W. 1999. Tuning biphenyl dioxygenase for extended substrate specificity. Biotech Bioeng 63:544-551.
10. Chartrain M, Mathre D, Reamer RA, Patel S, Shinkai I, Greasham R. 1997. Asymmetric bioreduction of cyclohexylphenyl alcohol by the yeast Candida magnoliae MY 1785. J Ferment Bioeng 83:395-396.
11. Chartrain M, McNamara J, Greasham R. 1996. Asymmetric bioreduction of benzyl acetoacetate to its corresponding alcohol, benzyl (S)-(+)-3-hydroxybutyrate by the yeast Candida schatavii MY 1831. J Ferment Bioeng 82:507-508.
12. Chartrain M, Roberge C, Chung J, McNamara J, Zhao D, Olewinski R, Hunt G, Salmon P, Roush D, Yamazaki S, Wang T, Grabowski E, Buckland B, Greasham R. 1999. Asymmetric reduction of 2-(4-nitro-phenyl)-N-(2-oxo-2-pyridin-3-yl-ethyl)-acetamide to its corresponding (R) alcohol (R)-N-(2-hydroxy-2-pyridin-3-ylethyl)-2-(4-nitro-phenyl)-acetamide by using Candida sorbophila MY 1833. Enz Micro Tech 25:489-496.
13. Collman JP, Zhang X, Lee VJ, Uffelman ES, Brauman JI. 1993. Regioselective and enantioselective epoxidation catalyzed by metalloporphyrins. Science 261:1404-1411.
14. de Bont JAM. 1998. Solvent-tolerant bacteria in biocatalysis. Tibtech 16:493-499.
15. di Gennaro P, Colmegna A, Galli E, Sello G, Pelizzoni F, Bestetti G. 1999. A new biocatalyst for production of optically pure aryl epoxides by styrene monooxygenase from Pseudomonas fluorescens ST. Appl Environ Microbiol 65:2794-2797.
16. Doig SD, Boam AT, Livingstone AG, Stuckey DC. 1999. Epoxidation of 1,7-octadiene by Pseudomonas oleovorans in a membrane bioreactor. Biotechnol Bioeng 63:601-611.
17. Draths KM, Frost JW. 1994. Environmentally compatible synthesis of adipic acid from D-glucose. J Am Chem Soc 116:399-400.
18. Draths KM, Ward TL, Frost JW. 1992a. Biocatalysis and nineteenth century organic chemistry: Conversion of D-glucose into quinoid organics. J Am Chem Soc 114:9725-9726.
19. Draths KM, Pompliano DL, Conley DL, Frost JW, Berry A, Disbrow GL, Staversky RJ, Lievense JC. 1992b. Biocatalytic synthesis of aromatics from d-glucose: The role of transketolase. J Am Chem Soc 114:3956-3962.
20. Faber K. 2000. Biotransformations in organic chemistry. Berlin: Springer Verlag.
21. Favre-Bulle O, Schouten T, Kingma J, Witholt B. 1991. Bioconversion of n-octane to octanoic acid by a recombinant Escherichia coli cultured in a two liquid phase bioreactor. Bio/Technol 9:367-371.
22. +) growing in a two-liquid-phase chemostat. Biotechnol Bioeng 41:263-272.
23. French CE, Hailes AM, Rathbone DA, Long MT, Willey DL, Bruce NC. 1995. Biological production of semisynthetic opiates using genetically engineered bacteria. Bio/Technology 13:674-676.
24. Furuhashi K. 1992. Biological routes to optically active epoxides. In Collins AN, Sheldrake GN, and Crosby J, editors. Chirality in industry. Chichester: Wiley. p 167-186.
25. Furuhashi K, Shintani M, Takagi M. 1986. Effects of solvents on the production of epoxides by Nocardia corallina B-276. Appl Microbiol Biotech 23:218-223.
26. Gonzalez FJ, Korzekwa KR. 1995. Cytochrome P450 expression systems. Ann Rev Pharm Toxicol 35:369-390.
27. Graham-Lorence S, Truan G, Peterson JA, Falck JR, Wei S, Helvig C, Capdevilla JC. 1997. An active site substitution, F87V, converts cytochrome P450 BM-3 into a regio- and stereoselective (14S,15R)-arachidonic acid epoxygenase. J Biol Chem 272:1127-1135.
28. Heipieper HJ, Weber FJ, Sikkema J, Keweloh H, de Bont JAM. 1994. Mechanisms of resistance of whole cells to toxic organic solvents. Tibtech 12:409-415.
29. Held M. 2000. PhD Thesis, ETH Zurich.
30. Held M, Panke S, Kohler HP-E, Feiten H-J, Schmid A, Schmid A, Wubbolts MG, Witholt B. 1999a. Solid phase extraction for biocatalytic production of toxic compounds. Bio World 5:2-9.
31. Held M, Schmid A, Kohler HPE, Suske W, Witholt B, Wubbolts MG. 1999b. An integrated process for the production of toxic catechols from toxic phenols based on a designer biocatalyst. Biotechnol Bioeng 62:641-648.
32. Jacobsen EN. 1993. Asymmetric catalytic epoxidation of unfunctionalized olefins. New York: VCH.
33. Jones NE, England PA, Rouch DA, Wong LL. 1996. Engineering the selectivity of aliphatic C-H bond oxidation catalysed by cytochrome P450cam. Chem Comm 20:2413-2414.
34. Joo H, Lin Z, Arnold FH. 1999. Laboratory evolution of peroxide-mediated cytochrome P450 hydroxylation. Nature 399:670-673.
35. Kerridge A, Willetts A, Holland H. 1999. Stereoselective oxidation of sulfides by cloned naphthalene dioxygenase. J Mol Cat B Enzym. 6:59-65.
36. Kieboom J, Dennis JJ, de Bont JAM, Zylstra GJ. 1998. Identification and molecular characterization of an efflux pump involved in Pseudomoans putida S12 solvent tolerance. J Biol Chem 273:85-91.
37. Kuchner O, Arnold FH. 1997. Directed evolution of enzyme catalysts. Tibtech 15:523-530.
38. Kumamaru T, Suenaga H, Mitsuoka M, Watanabe T, Furukawa K. 1998. Enhanced degradation of polychlorinated biphenyls by directed evolution of biphenyl dioxygenase. Nat Biotechnol 16:663-666.
39. Laane C, Boeren S, Vos K, Veeger C. 1987. Rules for optimization of biocatalysts in organic solvents. Biotechnol Bioeng. 30:81-87.
40. Lilly MD, Dervakos GA, Woodley JM. 1990. Two-liquid phase biocatalysis: Choice of phase ratio. In Copping LG, Martin RE, Pickett JE, Bucke C, and Bunch AW, editors. Opportunities in biotransformations. London: Elsevier. p 5-16.
41. Lye GJ, Woodley JM. 1999. Application of in situ product-removal techniques to biocatalytic processes. Trends Biotech 17:395-402.
42. Mathys RG, Ku OM, Witholt B. 1998. Alkanol removal from the apolar phase of a two-liquid phase bioconversion system. Part 1: Comparison of a less volatile and a more volatile in situ extraction solvent for the separation of 1-octanol by distillation. J Chem Technol Biotechnol 71:315-325.
43. May O, Nguyen PT, Arnold FH. 2000. Inverting enantioselectivity by directed evolution of hydantoinase for improved production of L-methionine. Nat Biotechnol 18:317-320.
44. McFall E, Newman EB. 1996. Amino acids as carbon sources. In Neidhardt FC, editor. Escherichia coli and Salmonella, vol. 1. Washington DC: ASM Press. p 358-379.
45. Ness JE, Welch M, Giver L, Bueno M, Cherry JR, Borchert TV, Stemmer WPC, Minshull J. 1999. DNA shuffling of subgenomic sequences of subtilisin. Nat Biotechnol 17:893-896.
46. cam towards styrene oxidation is increased by site-specific mutagenesis. FEBS Lett 405:153-156.
47. Nugent WA, Rajanbabu TV, Burk MJ. 1993. Beyond nature's chiral pool: Enantioselective catalysis in industry. Science 259:479-483.
48. O'Connor KE, Dobson ADW, Hartmans S. 1997. Indigo formation by microorganisms expressing styrene monooxygenase activity. Appl Environ Microbiol 63:4287-4291.
49. Ohkawa H, Yabusaki Y, Sakaki T, Murakami H, Shibata M. 1990. Hydroxylation reactions by recombinant yeast cells expressing P450 monooxygenases. Ann NY Acad Sci. 613:34-43.
50. Oliver CF, Modi S, Sutcliffe MJ, Primrose WU, Lian LY, Roberts GCK. 1997. A single mutation in cytochrome P450 BM3 changes substrate orientation in a catalytic intermediate and the regio-specificity of hydroxylation. Biochem 36:1567-1572.
51. Ostermeier M, Shim JH, Benkovic SJ. 1999. A combinatorial approach to hybrid enzymes independent of DNA homology. Nat Biotechnol 17:1205-1209.
52. Panke S, deLorenzo V, Kaiser A, Witholt B, Wubbolts MG. 1999a. Engineering of a stable whole-cell biocatalyst capable of (S)-styrene oxide formation for continuous two-liquid-phase applications. Appl Environ Microbiol 65:5619-5623.
53. Panke S, Meyer A, Huber CM, Witholt B, Wubbolts MG. 1999b. An alkane-responsive expression system for the production of fine chemicals. Appl Environ Microbiol 65:2324-2332.
54. Panke S, Witholt B, Schmid A, Wubbolts MG. 1998. Towards a biocatalyst for (S) styrene oxide production: Characterization of the styrene degradation pathway of Pseudomonas sp. VLB120. Appl Environ Microbiol 64:2032-2043.
55. Panke S, Wubbolts MG, Schmid A, Witholt B. 2000. Production of enantiopure styrene oxide by recombinant Escherichia coli synthesizing a two-component styrene monooxygenase. Biotechnol Bioeng 69:91-100.
56. Parikh A, Gillam AMJ, Guengerich FP. 1997. Drug Metabolism by Escherichia coli expressing human cytochromes p 450. Nat Biotechnol 15:784-788.
57. Park H-S, Lee J-Y, Kim H-S. 1998. Production of L-DOPA (3,4-dihydroxyphenyl-L-alanine) from benzene by using a hybrid pathway. Biotech Bioeng 58:339-343.
58. Ramos JL, Duque E, Godoy P, Segura A. 1998. Efflux pumps involved in toluene tolerance in Pseudomonas putida DOT-T1E. J Bacteriol 180:3323-3329.
59. Ramos JL, Duque E, Rodríguez-Herva JJ, Godoy P, Ha A, Reyes F, Fernández-Barrero A. 1997. Mechanisms for solvent tolerance in bacteria. J Biol Chem 272:3887-3890.
60. Reddy J, Lee C, Neeper M, Greasham R, Zhang J. 1999. Development of a bioconversion process for production of cis-1S,2R-indanediol from indene by recombinant Escherichia coli constructs. Appl Microbiol Biotechnol 51:614-620.
61. Reetz MT, Zonta A, Schimossek K, Liebeton K, Jaeger K-E. 1997. Creation of enantioselective biocatalysts for organic chemistry by in vitro evolution. Angew Chem Intern Ed Eng 36:2830-2832.
62. Ribeiro MH, Cabral JMS, Fonseca MMR. 1987. Production of L-tryptophan in a two-liquid phase system. In Laane C, Tramper J, and Lilly MD, editors. Biocatalysis in organic media. Amsterdam: Elsevier. p 323-329.
63. Rothen SA, Sauer M, Sonnleitner B, Witholt B. 1998. Biotransformation of octane by E. coli HB101[pGEc47] on defined medium: Octanoate production and product inhibition. Biotechnol Bioeng 58:356-365.
64. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: A laboratory manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
65. Schmid A, Sonnleitner B, Witholt B. 1998. Medium chain length alkane solvent-cell transfer rates in two-liquid phase, Pseudomonas oleovorans cultures. Biotechnol Bioeng 60:10-23.
66. Schmid A, Dordick JS, Hauer B, Kiener A, Wubbolts M, Witholt B. 2001a. Industrial biocatalysis today and tomorrow. Nature 409:258-268.
67. Schmid A, Hofstetter K, Feiten HJ, Hollmann F, Witholt B. 2001b. Integrated biocatalytic synthesis on gram scale: The highly enantio selective preparation of chiral oxiranes with styrene monooxygenase. Adv Synth Catal 343:732-737.
68. Shafiee A, Motamedi H, King A. 1998. Purification, characterization and immobilization of an NADPH-dependent enzyme involved in the chiral specific reduction of the keto ester M, an intermediate in the synthesis of an anti-asthma drug, Montelukast, from Microbacterium campoquemadoensis. Appl Microb Biotechnol 49:709-717.
69. Shet MS, Fisher CW, Estabrook RW. 1997. The function of recombinant cytochrome P450s in intact Escherichia coli cells: The 17 alpha-hydroxylation of progesterone and pregnenolone by p450c17. Arch Biochem Biophys 339:218-225.
70. Stahl S, Ikemoto N, King A, Greasham R, Chartrain M. 1999. Asymmetric direduction of 1,2-indanedione to cis (1S,2R) indanediol by Trichosporon cutaneum MY 1506. J Biosci Bioeng 88:495-499.
71. Stephenson GR. 1996. Asymmetric oxidation. In Stephenson GR, editor. Advanced asymmetric synthesis. London: Chapman & Hall. p 367-391.
72. Tsai JT, Wahbi LP, Dervakos GA, Stephens GM. 1996. Production of toluene-cis-glycol by a recombinant Escherichia coli in a two-liquid phase culture system. Biotechnol Lett 18:241-244.
73. Vicenzi JT, Zmijewski MJ, Reinhard MR, Landen BE, Muth WL, Marler PG. 1997. Large-scale stereoselective enzymatic ketone reduction with in situ product removal via polymeric adsorbent resins. Enz Microb Technol 20:494-499.
74. Wahbi LP, Gokhale D, Minter S, Stephens GM. 1996. Construction and use of recombinant Escherichia coli strains for the synthesis of toluene cis-glycol. Enz Microb Technol 19:297-306.
75. Wubbolts MG, Timmis KN. 1990. Biotransformation of substituted benzoates to the corresponding cis-diols by an engineered strain of Pseudomonas oleovorans producing the TOL plasmid-specified enzyme toluate-1,2-dioxygenase. Appl Environ Microbiol 56:569-571.
76. Wubbolts M, Reuvekamp P, Witholt B. 1994a. TOL plasmid-specified xylene oxygenase is a wide substrate range monooxygenase capable of olefin epoxidation. Enz Microb Technol 16:608-615.
77. Wubbolts MG, Hoven J, Melgert B, Witholt B. 1994b. Efficient production of optically active styrene epoxides in two-liquid phase cultures. Enz Microb Technol 16:887-893.
78. Wubbolts MG, Favre-Bulle O, Witholt B. 1996. Biosynthesis of synthons in two liquid phase media. Biotechnol Bioeng 52:301-308.
79. Zeyer J, Lehrbach PR, Timmis KN. 1985. Use of cloned genes of Pseudomonas TOL plasmid to effect biotransformation of benzoates to cis-dihydrodiols and catechols by Escherichia coli cells. Appl Environ Microbiol 50:1409-1413.
80. Zhao H, Giver L, Shao Z, Affolter JA, Arnold FH. 1998. Molecular evolution by staggered extension process (STEP) in vitro recombination. Nat Biotechnol 16:258-261.